43.3 Evaluation of Falls in Ambulatory & Older Patients

ABFM Family Medicine Certification Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making

1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care

2 Chapter 2: Healthcare Systems, Practice Management & Quality

2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination

3 Chapter 3: Ethics, Law, Biostatistics & Health Equity

3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism

4 Chapter 4: Lifestyle Counseling & Behavior Change

4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling

5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention

5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling

6 Chapter 6: Routine Adult Immunizations

6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise

7 Chapter 7: Pediatric Health Maintenance & Surveillance

7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride

8 Chapter 8: Behavioral Health & Safety Screening

8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling

9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic

9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening

10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic

10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling

11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate

11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making

12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception

12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C

13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care

13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam

14 Chapter 14: Emergent Cardiovascular Conditions

14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies

15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises

15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management

16 Chapter 16: Vascular & Thromboembolic Emergencies

16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion

17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness

17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion

18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies

18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies

19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies

19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice

20 Chapter 20: Acute Pulmonary & Airway Emergencies

20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction

21 Chapter 21: Acute Traumatic Injuries & Wound Care

21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites

22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies

22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises

23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies

23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection

24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies

24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis

25 Chapter 25: Hematologic, Urologic & Dental Emergencies

25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma

26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies

26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia

27 Chapter 27: Acute Head, Neck & Neurologic Symptoms

27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring

28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms

28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis

29 Chapter 29: Acute Upper Respiratory Tract Infections

29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion

30 Chapter 30: Acute Lower Respiratory Infections & Cough

30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia

31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions

31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation

32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms

32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation

33 Chapter 33: Acute Upper Gastrointestinal Conditions

33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness

34 Chapter 34: Acute Lower Gastrointestinal Conditions

34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani

35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders

35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes

36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders

36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis

37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions

37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation

38 Chapter 38: Acute Infectious Dermatoses

38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum

39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses

39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma

40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries

40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains

41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries

41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes

42 Chapter 42: Acute Ambulatory Fractures & Dislocations

42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation

43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls

43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients

44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain

44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies

45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions

45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction

46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions

46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation

47 Chapter 47: Acute Women's Health & Early Pregnancy Care

47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder

48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination

48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis

49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections

49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses

50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia

50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT

51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases

51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy

52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD

52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria

53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus

53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance

54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases

54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition

55 Chapter 55: Chronic Endocrine Disorders

55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders

56 Chapter 56: Chronic Kidney Disease & Venous Disorders

56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD

57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases

57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy

58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care

58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders

59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders

59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome

60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders

60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care

61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders

61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness

62 Chapter 62: Chronic Psychiatric Disorders

62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder

63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions

63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating

64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation

64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy

65 Chapter 65: Chronic Dermatologic Conditions

65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus

66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care

66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control

67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit

67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit

43.3 Evaluation of Falls in Ambulatory & Older Patients

Key Takeaways Explain This Topic AI

Falls are the leading cause of fatal and non-fatal accidental injuries in adults aged >=65, with more than one in four community-dwelling older adults falling each year and post-fall 'fear of falling' frequently initiating a spiral of physical deconditioning.

The CDC STEADI framework establishes an annual screening protocol using three questions (past falls, feeling unsteady, worry about falling); patients reporting a fall with injury, >=2 falls in the past year, or abnormal mobility testing require a comprehensive multifactorial fall risk evaluation.

Objective mobility and balance testing provides quantitative fall risk stratification: a Timed Up and Go (TUG) score >=12 seconds, impaired 30-second chair stand performance, or inability to maintain a full tandem balance stance for 10 seconds indicates significantly elevated fall risk.

Medication reconciliation and deprescribing targeting Fall-Risk Increasing Drugs (FRIDs)—including psychotropics (benzodiazepines, Z-drugs, sedating antidepressants, antipsychotics), anticholinergics, sulfonylureas, and vasodilators causing orthostasis—represent an essential preventive intervention.

Structured multicomponent exercise interventions that emphasize balance, gait, and functional strength training (such as Tai Chi) carry a USPSTF Grade B recommendation as the single most effective intervention to reduce falls in community-dwelling older adults, whereas the USPSTF explicitly recommends against routine vitamin D supplementation solely for fall prevention in those without deficiency or osteoporosis (Grade D).

Last updated: September 2026

Epidemiology, Clinical Impact & The CDC STEADI Protocol

Falls are the leading cause of accidental injury death and non-fatal trauma among adults aged 65 years and older in the United States. Each year, more than one in four community-dwelling older adults experiences a fall , resulting in over 3 million emergency department visits, 800,000 hospitalizations, and 34,000 fatalities annually.

Clinical Morbidity & The Post-Fall Syndrome

Physical Trauma : More than 95% of hip fractures in older adults are directly caused by falling sideways onto the greater trochanter. Falls are also the primary cause of traumatic brain injury (TBI) and acute/chronic subdural hematomas in older patients, who are often on concurrent antiplatelet or anticoagulant pharmacotherapy.

The Psychological Impact ("Fear of Falling") : Following a fall (or even a near-fall), up to 50% of older individuals develop an intense, debilitating fear of falling (ptophobia). This psychological trauma prompts voluntary restriction of physical activities, leading to rapid skeletal muscle sarcopenia, joint contractures, loss of balance confidence, social isolation, depression, and functional institutionalization.

The CDC STEADI Clinical Framework

The Centers for Disease Control and Prevention (CDC) developed the STEADI (Stopping Elderly Accidents, Deaths, & Injuries) algorithm to guide primary care clinicians through systematic screening, risk stratification, and targeted multifactorial intervention. CDC STEADI FALL SCREENING ALGORITHM

• [Annual Wellness Visit / Routine Screening for Adults Aged >= 65 Years]
• │
• ▼

ASK THE 3 CARDINAL SCREENING QUESTIONS:

1. Have you fallen in the past year?

2. Do you feel unsteady when standing or walking?

3. Do you worry about falling?

• │
• ┌───────────────┴───────────────┐
• ▼ ▼
• [NO to ALL 3 Questions] [YES to ANY Question]
• Patient is at LOW RISK • Patient is SCREEN POSITIVE
• Provide preventive education • Assess Fall History & Injury
• Recommend physical activity/ • Administer Objective Mobility Tests
• community exercise (Tai Chi) (TUG, Chair Stand, 4-Stage Balance)
• Rescreen annually │
• ┌───────────────┴───────────────┐
• ▼ ▼
• [MODERATE RISK] [HIGH RISK]
• 1 fall without injury • >= 2 falls in past year, OR
• Normal mobility tests • 1 fall WITH an injury, OR
• Treat identified risks (gait, meds) • ABNORMAL mobility test (TUG >=12s)
• │
• ▼
• [COMPREHENSIVE MULTIFACTORIAL
• FALL RISK ASSESSMENT]
• 1. Medication deprescribing (FRIDs)
• 2. Orthostatic vitals & cardiovascular
• 3. Vision, neuropathy & cognition
• 4. Podiatry & footwear counseling
• 5. Home safety OT evaluation
• 6. Physical Therapy / Tai Chi referral
• Objective Mobility, Gait & Balance Assessments

When an older patient screens positive on the initial 3 questions, the clinician must quantify functional mobility, lower extremity strength, and dynamic postural stability using standardized, validated assessment tools.

1. Timed Up and Go (TUG) Test

Protocol : The patient sits comfortably in a standard armchair with their back against the chair. On the command "Go", the patient rises from the chair, walks a distance of 3 meters (10 feet) at a normal, comfortable pace, crosses a marked line on the floor, turns around, walks back to the chair, and sits down completely.

Scoring & Interpretation :

<10 seconds : Normal functional mobility; completely independent.

10 to 11 seconds : Borderline mobility; normal for some frail elderly individuals.

>=12 seconds : High Fall Risk . A TUG score of 12 seconds or greater indicates impaired functional mobility, poor dynamic balance, and significantly elevated future fall risk in community-dwelling older adults, mandating a comprehensive multifactorial workup.

Qualitative Observations : The examiner should observe: hesitations upon standing, pushing up with hands, unsteadiness during turns, path deviation, shuffling, or decreased arm swing.

2. 30-Second Chair Stand Test

Protocol : The patient sits in an armless standard-height chair (17 inches) with feet flat on the floor and arms crossed over their chest. On "Go", the patient rises to a full standing position and sits back down as many times as possible within 30 seconds.

Interpretation : Evaluates proximal lower extremity muscle strength (primarily quadriceps femoris) and muscular endurance. Below-average scores (e.g., <10 to 12 stands for a 70-year-old) correlate with sarcopenia, weakness, and difficulty climbing stairs or rising from a toilet without assistance.

3. 4-Stage Balance Test

Protocol : The patient attempts to hold four progressively challenging standing postures for 10 seconds each without external physical support or assistive devices:

Side-by-side stance : Feet placed together side by side.

Semi-tandem stance : The instep of one foot touches the big toe of the other foot.

Full tandem stance : The heel of one foot is placed directly in front of and touching the toes of the other foot.

Single-leg stance : Standing on one foot without touching the other leg.

Interpretation : Inability to hold the full tandem stance for 10 seconds is a validated, independent marker of impaired postural equilibrium and increased fall risk.

The Systematic Multifactorial Fall Assessment

A multifactorial fall evaluation systematically investigates five major domains: medications, cardiovascular stability, sensory/neurological function, musculoskeletal/foot mechanics, and the domestic environment. THE 5 CLINICAL DOMAINS OF FALL EVALUATION

• Domain High-Yield Pathologies & Diagnostic Targets
• ═════════════════════════════════════════════════════════════════════════════════════════

1. Pharmacotherapy • Deprescribe Fall-Risk Increasing Drugs (FRIDs):

• & Polypharmacy Psychotropics, sedatives, anticholinergics, sulfonylureas
• Review Beers Criteria & STOPP/START guidelines

• 2. Cardiovascular & • Orthostatic vital signs (drop in SBP >=20 mmHg or DBP >=10 mmHg)
• Hemodynamics • Arrhythmia screening, carotid sinus hypersensitivity, 12-lead ECG
• Structural heart disease (aortic stenosis, HCM)

• 3. Neurologic & • Peripheral neuropathy (10-g monofilament, 128-Hz vibration)
• Sensory Screening • Visual acuity (cataracts, macular degeneration, multifocal glasses)
• Vestibular dysfunction (Dix-Hallpike for BPPV)
• Cognitive impairment (Mini-Cog, MoCA: dual-task deficits)

• 4. Musculoskeletal & • Sarcopenia, proximal hip/knee osteoarthritis
• Podiatric Mechanics • Foot deformities (bunions, calluses, onychogryphosis)
• Footwear: Replace floppy slippers/bare feet with thin, firm soles

• 5. Domestic Home • Remove throw rugs, eliminate clutter and electrical cords
• Safety Hazards • Install bathroom grab bars, raised toilet seats, stair handrails
• High-wattage non-glare lighting and motion-sensor nightlights
• ═════════════════════════════════════════════════════════════════════════════════════════
• 1. Medication Review & Deprescribing: The FRIDs

Polypharmacy (concurrent use of >=5 medications) and specific drug classes dramatically increase fall risk through sedation, cerebellar ataxia, psychomotor slowing, orthostatic hypotension, and hypoglycemia.

Fall-Risk Increasing Drugs (FRIDs) - Key Classes :

Psychotropics & Sedatives : Benzodiazepines (e.g., lorazepam, alprazolam), non-benzodiazepine GABA-A agonists / "Z-drugs" (e.g., zolpidem, eszopiclone), first- and second-generation antipsychotics, and sedating tricyclic antidepressants (amitriptyline). Even SSRIs and SNRIs confer elevated fall risk via sedation, sleep disturbance, and hyponatremia (SIADH).

Anticholinergic Agents : First-generation antihistamines (diphenhydramine, hydroxyzine), bladder antispasmodics (oxybutynin), and skeletal muscle relaxants.

Antihypertensives & Diuretics : Alpha-1 adrenergic blockers (e.g., doxazosin, terazosin, tamsulosin), high-dose loop or thiazide diuretics causing hypovolemia, and vasodilators. Overly aggressive blood pressure lowering in frail elders impairs cerebral autoregulation.

Opioid Analgesics : Cause central sedation, slowed reaction time, and dizziness.

Hypoglycemic Agents : Sulfonylureas (especially long-acting glyburide and glimepiride) and sliding-scale insulin regimens triggering neuroglycopenic falls.

Deprescribing Protocol : Perform systematic drug reconciliation using Beers Criteria and STOPP (Screening Tool of Older Persons' Prescriptions) . Prioritize gradual tapering and discontinuation of psychotropics, substitute non-pharmacologic behavioral therapy for insomnia (CBT-I), and liberalize strict glycemic (target HbA1c 7.5% to 8.5% in frail elders) and blood pressure targets.

2. Cardiovascular & Hemodynamic Evaluation

Orthostatic Vital Signs Protocol :

Measure blood pressure and heart rate after the patient has rested supine or seated for 5 minutes.

Re-measure blood pressure and heart rate at 1 minute and 3 minutes after the patient stands upright.

Diagnostic Threshold : A drop in systolic BP >=20 mmHg OR a drop in diastolic BP >=10 mmHg within 3 minutes of standing constitutes orthostatic hypotension.

Management : Taper offending vasodilators/diuretics, ensure adequate hydration (1.5 to 2 L/day if no heart failure), recommend waist-high compression stockings, and consider pharmacotherapy (fludrocortisone or midodrine) only in refractory, symptomatic neurogenic cases.

Distinguishing Mechanical Falls from Syncope :

Sudden, unexplained falls without warning, loss of consciousness, post-event confusion, or palpitations require a syncope evaluation: baseline 12-lead ECG (to detect atrioventricular blocks, prolonged QTc, sick sinus syndrome), echocardiography (to rule out severe aortic stenosis), and ambulatory cardiac telemetry.

3. Neurologic & Sensory Evaluation

Peripheral Neuropathy : Test sensory loss using a Semmes-Weinstein 10-gram monofilament at the plantar surface of the great toe, 1st, 3rd, and 5th metatarsal heads, combined with vibratory testing using a 128-Hz tuning fork and proprioception at the distal interphalangeal joints.

Vision Screening & The Multifocal Lens Hazard :

Screen with a Snellen eye chart; evaluate for cataracts, open-angle glaucoma, and age-related macular degeneration.

The Multifocal / Bifocal Hazard : Bifocal, trifocal, and progressive lenses blur lower peripheral vision and distort depth perception when looking downward at stairs, curbs, or floor obstacles. Clinicians must advise older adults to wear single-vision distance glasses when walking outdoors, using public transit, or navigating staircases.

Cognitive Impairment Screening : Screen with the Mini-Cog (3-word registration, clock drawing test to 11:10, 3-word recall) or MoCA. Cognitive deficits impair divided attention ("dual-tasking"), preventing older adults from compensating for postural perturbations while talking or carrying objects while walking.

4. Musculoskeletal & Footwear Counseling

Sarcopenia & Osteoarthritis : Assess hip and knee active/passive range of motion, crepitus, and joint effusions.

Podiatric Pathology : Inspect feet for hallux valgus, hammer toes, painful corns, hyperkeratotic calluses, and onychogryphosis (thickened dystrophic toenails) causing antalgic, unsteady gait.

Footwear Counseling :

High-Risk Footwear : Walking barefoot, wearing stocking feet, or wearing loose, backless, floppy slippers, clogs, or high-heeled shoes increases fall risk up to tenfold!

Recommended Footwear : Flat, low-heeled (heel height <1 inch), firm-soled shoes with non-skid rubber tread and secure closures (laces or Velcro) that encase the heel collar and provide rearfoot stability.

5. Environmental Home Hazard Modification

More than 50% to 60% of all falls occur within the patient's own residence. An environmental checklist should address:

Throw Rugs & Clutter : Remove all loose throw rugs and area carpets; secure runners with double-sided anti-slip tape; clear electrical extension cords, telephone wires, and low furniture from primary walking pathways.

Lighting : Replace dim bulbs with 100-watt glare-free bulbs; install motion-activated nightlights along the pathway between the bedroom and bathroom; place bedside lamps within arm's reach of the bed.

Bathroom Safety : Install professionally anchored grab bars (mounted into wall studs, rated for 250+ lbs) inside showers, adjacent to tubs, and next to toilets (caution patients to never use towel racks or toilet paper holders as grab bars ); place non-skid rubber suction mats inside bathtubs; use a raised toilet seat and a shower chair.

Stairways : Secure sturdy, continuous handrails on both sides of all indoor and outdoor staircases; paint or apply high-contrast non-skid adhesive strips to the leading edges (nosings) of steps.

Evidence-Based Clinical Interventions: USPSTF Recommendations USPSTF RECOMMENDATIONS ON FALL PREVENTION

• Clinical Intervention USPSTF Grade Clinical Recommendation Summary
• ═════════════════════════════════════════════════════════════════════════════════════════
• Structured Exercise Grade B RECOMMENDED: Prescribe structured exercise
• Interventions (Gait, interventions (balance, gait, strength;
• Balance, Strength; Tai Chi) e.g., Tai Chi) for community-dwelling adults

aged >=65 at increased risk of falls.

• Multifactorial Clinical Grade B / C OFFER SELECTIVELY: Comprehensive assessment
• Interventions (Customized) and individualized multifactorial care based on

individual risk profile and preferences.

• Routine Vitamin D Grade D RECOMMENDS AGAINST: Do NOT routinely prescribe
• Supplementation Solely vitamin D solely for fall prevention in
• for Fall Prevention community-dwelling older adults without proven

deficiency or osteoporosis.

• ═════════════════════════════════════════════════════════════════════════════════════════
• 1. Structured Exercise Interventions (USPSTF Grade B Recommendation)

Structured physical exercise is the single most effective standalone intervention to prevent falls in community-dwelling older adults, demonstrating an average relative risk reduction of 20% to 30% in fall rates across randomized controlled trials.

Optimal Exercise Components : Programs must include dynamic balance retraining, agility/gait training, and progressive resistance strength training for a minimum of 2 to 3 hours per week.

Tai Chi : A traditional Chinese mind-body martial art characterized by slow, continuous, flowing movements, weight shifting, trunk rotation, and focused postural alignment. Tai Chi significantly enhances proprioceptive feedback, strengthens lower extremity extensor muscles, and trains dynamic perturbation recovery. Meta-analyses demonstrate that Tai Chi reduces fall frequency by up to 40% to 50% in older adults.

Otago Exercise Program : An evidence-based, physical therapist-delivered home program consisting of 17 balance and muscle-strengthening exercises, progressing with ankle cuff weights, combined with a walking plan.

2. Occupational Therapy Home Safety Assessments

Comprehensive in-home safety evaluations conducted by an Occupational Therapist (OT) result in significant fall reductions, especially among individuals who are at high fall risk or who have had prior fall hospitalizations. The OT tailors adaptations to the patient's specific functional deficits.

3. The USPSTF Recommendation on Vitamin D: Debunking the Myth

Caution

USPSTF GRADE D RECOMMENDATION: VITAMIN D & FALL PREVENTION The United States Preventive Services Task Force (USPSTF) explicitly recommends AGAINST routine vitamin D supplementation solely for the prevention of falls in community-dwelling older adults aged >=65 years without documented vitamin D deficiency or osteoporosis.

Large-scale randomized clinical trials have conclusively shown that routine vitamin D supplementation does not reduce fall rates in unselected community-dwelling older adults. Furthermore, high-dose intermittent bolus regimens (e.g., 500,000 IU orally once annually or 60,000 IU monthly) paradoxically INCREASE fall and fracture rates ! Clinicians should test for and treat true biochemical vitamin D deficiency (serum 25-hydroxyvitamin D <20 ng/mL) for skeletal health, but should not prescribe empiric vitamin D as a fall prevention panacea.

Loading diagram... Comprehensive CDC STEADI Fall Evaluation & Prevention Pathway